Advertisement
HALO vs VRTX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Hold and VRTX is a Buy.
HALO in -16.30% downward trend, falling for three consecutive days on November 09, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HALO declined for three days, in 163 of 272 cases, the price declined further within the following month. The odds of a continued downward trend are 60%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HALO as a result. In 46 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for HALO turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 20 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
HALO moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where HALO advanced for three days, in 276 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
HALO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 257 of 328 cases where HALO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. HALO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HALO's P/B Ratio (81.939) is slightly higher than the industry average of (3.498). P/E Ratio (29.192) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (7.968) is also within normal values, averaging (440.869).
VRTX in upward trend: 10-day moving average crossed above 50-day moving average on October 30, 2026
The 10-day moving average for VRTX crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on VRTX as a result. In 61 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for VRTX just turned positive on October 20, 2026. Looking at past instances where VRTX's MACD turned positive, the stock continued to rise in 43 of 59 cases over the following month. The odds of a continued upward trend are 73%.
VRTX moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRTX advanced for three days, in 235 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 174 of 291 cases where VRTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
Bearish Trend Analysis
The 10-day RSI Indicator for VRTX moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 25 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 63 cases where VRTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 48%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
VRTX broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. VRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.848) is normal, around the industry mean (3.498). P/E Ratio (31.605) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (1.939) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (10.449) is also within normal values, averaging (440.869).
HALO | VRTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 14 | 13 | |
SMR RATING 1..100 | 11 | 41 | |
PRICE GROWTH RATING 1..100 | 42 | 24 | |
P/E GROWTH RATING 1..100 | 5 | 36 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VRTX's Valuation (91) in the Biotechnology industry is in the same range as HALO (98). This means that VRTX’s stock grew similarly to HALO’s over the last 12 months.
VRTX's Profit vs Risk Rating (13) in the Biotechnology industry is in the same range as HALO (14). This means that VRTX’s stock grew similarly to HALO’s over the last 12 months.
HALO's SMR Rating (11) in the Biotechnology industry is in the same range as VRTX (41). This means that HALO’s stock grew similarly to VRTX’s over the last 12 months.
VRTX's Price Growth Rating (24) in the Biotechnology industry is in the same range as HALO (42). This means that VRTX’s stock grew similarly to HALO’s over the last 12 months.
HALO's P/E Growth Rating (5) in the Biotechnology industry is in the same range as VRTX (36). This means that HALO’s stock grew similarly to VRTX’s over the last 12 months.
| HALO | VRTX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 87% | 2 days ago 57% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 48% |
| Momentum ODDS (%) | 2 days ago 60% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 56% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 68% |
| Advances ODDS (%) | 14 days ago 82% | 3 days ago 64% |
| Declines ODDS (%) | 3 days ago 60% | 9 days ago 44% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 47% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 60% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HALO’s FA Score shows that 3 FA rating(s) are green while VRTX’s FA Score has 2 green FA rating(s).
- HALO’s FA Score: 3 green, 2 red.
- VRTX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HALO’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 6 bullish TA indicator(s).
- HALO’s TA Score: 5 bullish, 4 bearish.
- VRTX’s TA Score: 6 bullish, 4 bearish.
Price Growth
HALO (@Biotechnology) experienced а -19.93% price change this week, while VRTX (@Biotechnology) price change was +3.23% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
HALO is expected to report earnings on Feb 23, 2027.
VRTX is expected to report earnings on Feb 09, 2027.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement